Litcius/Paper detail

Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis

D Rosenberg, Deven Deonarain, Jonah Gould, Amirthan Sothivannan, Mark Phillips, Gurkaran S. Sarohia, Sobha Sivaprasad, Charles C. Wykoff, Chui Ming Gemmy Cheung, David Sarraf, Sophie J. Bakri, Varun Chaudhary

2022Eye79 citationsDOIOpen Access PDF

Topics & Concepts

MedicineDosingAfliberceptPro re nataRanibizumabRegimenVisual acuityObservational studyRandomized controlled trialMeta-analysisMacular degenerationInternal medicineBevacizumabOphthalmologySurgeryChemotherapyRetinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal Development and Disorders
Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis | Litcius